Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

OBJECTIVES: The purpose of this study was to investigate the effects of mineralocorticoid receptor antagonists (MRAs) on systolic blood pressure (SBP) and outcomes according to baseline SBP in patients with heart failure with reduced ejection fraction (HFrEF). BACKGROUND: MRAs are greatly underused...

Descripción completa

Detalles Bibliográficos
Autores principales: Serenelli, Matteo, Jackson, Alice, Dewan, Pooja, Jhund, Pardeep S., Petrie, Mark C., Rossignol, Patrick, Campo, Gianluca, Pitt, Bertram, Zannad, Faiez, Ferreira, João Pedro, McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086149/
https://www.ncbi.nlm.nih.gov/pubmed/31926854
http://dx.doi.org/10.1016/j.jchf.2019.09.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086149/
https://www.ncbi.nlm.nih.gov/pubmed/31926854
http://dx.doi.org/10.1016/j.jchf.2019.09.011

Ejemplares similares